Kenneth Carter

Kenneth C.
Carter is the founder.
Founded NexImmune, Inc. in 2011 as Chairman, President & Chief Executive Officer.
Founded Avalon Pharmaceuticals, Inc. in 1999 as President & Chief Executive Officer.
Founded Noble Life Sciences, Inc. in 2010 as Chairman.
Dr. Carter is also the founder of Noble BioVentures LLC,NeoDiagnostix, Inc. Current job at Iterion Therapeutics, Inc. as Director since 2011.
Current job at MdBio, Inc. as Director.
Current job at Maryland Health Care Product Development Corp.
as Director since 2007.
Current job at Biohealth Innovation, Inc. as Director.
Current job at Apollomics, Inc. (United States) as Independent Director since 2023.
Current job at Antidote Therapeutics, Inc. as Director since 2016.
Current job at Neuimmune, Inc. as Director.
Former job at Seneca Biopharma, Inc. as Executive Chairman in 2021.
Former job at Apollomics, Inc. as Independent Director from 2023 to 2025.
Former job at Human Genome Sciences, Inc. as Senior Scientist from 1993 to 1999.
Education from Abilene Christian University with an undergraduate degree.
Education from the University of Texas Medical Branch with a doctorate degree.